The molecular basis for electrogenic computation in the brain: you can't step in the same river twice SG Waxman
For a number of neurological disorders which show anticipation (increased severity and decreased age of onset in successive generations), the cause is linked to tracts of repeats of a three nucleotide sequence. This expands with an increase in the number of repeats in affected individuals, with larger repeats causing earlier onset and more severe symptoms. Anticipation has also been reported for schizophrenia and bipolar disorder. Several reports have indicated larger tracts of the repeat triplet CAG/CTG in schizophrenia and bipolar affected individuals compared to unaffected individuals, suggesting that there may be trinucleotide repeat mutations associated with these disorders. In this study, the authors have performed an analysis of CAG/CTG tracts in DNA for 95 schizophrenia individuals and matched controls, as well as 91 bipolar individuals and matched controls. They found no association of large repeat tracts with either disease, either genome-wide using the RED technique or at two specific repeat sites that are frequently expanded. A Sharma, ML Kramer, PF Wick, D Liu, S Chari, S Shim, D Ouellette, M Nagata, CJ DuRand, M Kotb, RC Deth D4 dopamine receptors (D4Rs) are thought to play a unique role in attention and cognitive processes, but their mechanism of involvement has remained unclear. This study finds that D4Rs have the unique ability to facilitate phospholipid methylation (PLM), a process which reduces the membrane packing density which may in turn modulate the activity of other receptors. D4R-mediated PLM depends upon the supply of methyl groups from the folate pathway, and a number of psychiatric diseases are known to involve impairments of either folate metabolism or folate-dependent metabolic pathways. Lymphocytes from schizophrenic patients showed only 25% of normal PLM activity, illustrating the possibility that psychiatric illnesses might result from altered D4R-mediated PLM. Moreover, growth-dependent changes in folate metabolism could trigger the onset of schizophrenia. Discovery of this new D4R signalling pathway may lead to novel diagnostic and treatment opportunities.
D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia
Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia R Segman, T Neeman, U Heresco-Levy, B Finkel, L Karagichev, M Schlafman, A Dorevitch, A Yakir, A Lerner, A Shelevoy, B Lerer Dopamine receptor blockade is a common feature of classical antipsychotic drugs that is important for their therapeutic effect. It is also thought to underlie their propensity to induce tardive dyskinesia (TD), an often irreversible adverse effect consisting of involuntary abnormal movements, in one fifth of schizophrenia patients requiring chronic drug treatment. The authors examined the association of a common polymorphism in the gene encoding the dopamine D3 receptor (DRD3) with TD. They found a highly significant excess of genotypes containing the mutant allele which results in a serine to glycine substitution in the DRD3 protein, in schizophrenia patients with TD, as compared with schizophrenia patients without TD and normal controls. Schizophrenia patients with these genotypes show significantly higher scores of abnormal movements. These results support and extend the report by Steen and colleagues of an association between DRD3 and TD in schizophrenia patients.
HKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissue and localization to chromosome 1q21
The authors demonstrate a significant association between longer CAG repeats in the hKCa3/KCNN3 calcium-activated potassium channel gene and schizophrenia in Israeli Ashkenazi Jews. The distribution of CAG repeat lengths is significantly different in 84 patients vs 102 matched controls (P = 0.00017, Wilcoxon Rank Sum test), with patients showing greater lengths. Northern blots reveal substantial levels of hKCa3/KCNN3 transcripts (ෂ9 kb and ෂ13 kb in length) in brain, striated muscle, spleen and lymph nodes. Within the brain, higher levels of transcript are seen in the substantia nigra than in the basal ganglia, amygdala, hippocampus and subthalamic nuclei, while little is seen in the cerebral cortex, cerebellum or thalamus. In situ hybridization reveals abundent hKCa3/KCNN3 message localized within the substantia nigra and ventral tegmental area, and along the distributions of dopaminergic neurons from these regions into the nigrostriatal and mesolimbic pathways. FISH analysis shows that hKCa3/KCNN3 is located on chromosome 1q21.
Mapping of hKCa3 of chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia CP Austin, DJ Holder, L Ma, LA Mixson, CT Caskey
Several reports have hypothesized that the calciumactivated potassium channel gene hKCa3 is a candidate for schizophrenia susceptibility, based on its chromosomal location in a schizophrenia locus and the association of larger intragenic CAG repeat numbers with schizophrenia. The authors looked for evidence of this association in a family-based study, utilizing pedigrees from the NIMH Schizophrenia Genetics Initiative. They found no evidence that the number of CAG repeats in hKCa3 was different between schizophrenics and control siblings, or that parents transmitted hKCa3 alleles with large CAG repeat numbers more often to schizophrenic progeny than would be expected by chance. A family-based association study using 193 offspring/parent combinations was performed, in order to evaluate a recently reported case-control study on the potential association of a polymorphic trinucleotide polymorphism within the small calcium-regulated potassium channel gene (hSKCa3) with schizophrenia. No support was obtained either for a difference in allele frequency distribution or for association of longer alleles with schizophrenia using the transmission disequilibrium test.
Genetic association study of a polymorphic CAG repeats array of calclum-activated potassium channel (KCNN3) gene and schizophrenia among Chinese population from Taiwan
M-T Tsai, C-K Shaw, K-J Hsiao, C-H Chen
Two recent genetic association studies published in Molecular Psychiatry suggested that a polymorphic CAG trinucleotide repeats array of a calcium-activated potassium channel (KCNN) gene is associated with susceptibility of schizophrenia. In those two reports, schizophrenic patients were found to have a significantly higher proportion of larger CAG repeats (Ͼ 19) than the unaffected general population. This finding was found to be true mostly for Caucasians. The authors were interested to find out if the same result could be obtained in a Chinese population. The authors carried out a replication study in 92 Chinese schizophrenic patients and 100 unaffected controls from Taiwan, however no association was observed. The data added further evidence of genetic heterogeneity in schizophrenia in different ethnic backgrounds. Furthermore, the authors described a more rapid, efficient and unambiguous method to determine the genotype of CAG repeats allele, which should facilitate replication studies by other research groups.
Mutational analysis of phospholipaseA2A: a positional candidate susceptibility gene for bipolar disorder N Jacobsen, E Franks, M Owen, N Craddock
The authors have previously described the cosegregation of Darier's disease, an autosomal dominant skin disorder, and bipolar affective disorder (manic depression) in a family from North Wales. The gene for Darier's disease was mapped by several independent groups to chromosome 12q23-24.1. An analysis was performed on 45 bipolar families and evidence was found for genetic linkage with chromosome 12q peaking at a marker within the phospholipaseA2A gene. The phospholipaseA2A gene is thought to be involved in the regulation of cell membrane fluidity and certain proteins that may have links to susceptibility to bipolar disorder. In this study the authors have analyzed the phospholipaseA2A gene for mutations in order to ascertain whether it plays a role in determining susceptibility to bipolar disorder. They conclude that this gene is unlikely to determine disease susceptibility in their patient sample.
Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders
The serotonin transporter gene (5-HTTLPR) is receiving increasing interest in psychiatric genetic research. As its association with anxiety trait in normals, 5-HTTLPR has been associated with a number of psychiatric disturbances including mood disorders and antidepressant response. The authors investigated the possibility that the 5-HTTLPR might be associated with depressive symptomatology in a sample of mood disorder subjects. 5-HTTLPR variants were not associated with total depressive symptomatology, but the short 5-HTTLPR variant was associated with higher psychic anxiety scores. The upstream regulatory region of the serotonin transporter gene is not, therefore, a major influence on the depressive symptomatology in mood disorder subjects but the authors suggest that it may be a liability factor for anxiety symptomatology also in mood disorder subjects. JL Kennedy, J Bradwejn, D Koszycki, N King, R Crowe, J Vincent, O Fourie Panic disorder, which affects 2% of men and 5% of women, has been shown to have a strong genetic component. There is strong evidence implicating the cholecystokinin (CCK) neurotransmitter system in this disorder. In the current study, the authors have examined three markers in the CCK system-namely, polymorphisms in the CCK pre pro hormone gene, and in the CCK-A and B receptors. Comparing the frequency of alleles in panic disorder subjects to those in an ethnically similar, healthy control population of the same sex and age, no differences were observed for the CCK pre pro hormone or CCK-A receptor genes. However, for the CCK-B receptor marker, there was a significant increase in the frequency of alleles 6 and 7 in the patient sample, compared to controls, suggesting a possible role for this gene as a modifying factor in conferring susceptibility to panic disorder.
Investigation of cholecystokinin genes in panic disorder
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism J Tiihonen, T Hallikainen, H Lachman, T Saito, J Volavka, J Kauhanen, JT Salonen, O-P Ryynä nen, M Koulu, MK Karvonen, T Pohjalainen, E Syvä lahti, J Hietala Catechol-O-methyltransferase (COMT) is an enzyme which has a crucial role in the metabolism of dopamine, and a common functional genetic polymorphism in the COMT gene results in 3 to 4-fold differences in COMT enzyme activity. Since ethanol-induced euphoria is associated with the rapid release of dopamine in limbic areas, it is conceivable that subjects who inherit the allele encoding the low activity COMT variant would have a relatively low dopamine inactivation rate, and therefore would be more vulnerable to the development of ethanol dependence. The authors compared the high (H) and low (L) activity COMT genotype and allele frequencies of two independent male late onset (type 1) alcoholic populations with previously published data from Finnish blood donors (general population) and race-and gender-matched controls. The frequency of low activity allele (L) and LL genotype was markedly higher among the alcoholics when compared with the general population and with the controls. The estimate for population etiological (attributable) fraction for the LL genotype in alcoholism was 13%, which indicates that the COMT polymorphism contributes significantly to the development of late-onset alcoholism.
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers EG Jö nsson, MM Nö then, F Grü nhage, L Farde, Y Nakashima, P Propping, GC Sedvall
The density of striatal dopamine D2 receptors has been shown to vary considerably among healthy subjects. This variability might be due to genetic or environmental factors. The authors investigated relationships between four common dopamine D2 receptor gene (DRD2) polymorphisms and striatal dopamine D2 receptor density in vivo, as measured by positron emission tomography (PET) in 56 healthy subjects. There was a significant association between a DRD2 promoter allele (−141C Del) and high striatal dopamine receptor density. In agreement with previous post-mortem and PET studies the presence of the DRD2 TaqIA1 allele was associated with measures of low dopamine receptor density. Also the DRD2 TaqIB1 allele was associated with low dopamine receptor density. It is suggested that DRD2 genotypes may participate differentially in the regulation of striatal dopamine D2 receptor density in healthy human subjects. J Licinio, MD Editor
